Nango, Teodora .
HRN: 01-24-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
LEVOFLOXACIN 500MG (TAB)
09/13/2022
09/19/2022
PO
500 Mg
OD
UTI
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes